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Regulation of ghrelin receptor by 
microbial and inflammatory signals in 
human osteoblasts
Abstract : Recently, it has been suggested that the anti-inflammatory 
hormone ghrelin (GHRL) and its receptor GHS-R may play a 
pivotal role in periodontal health and diseases. However, their 
exact regulation and effects in periodontitis are not known. The 
aim of this in-vitro study was to investigate the effect of microbial 
and inflammatory insults on the GHS-R1a expression in human 
osteoblast-like cells. MG-63 cells were exposed to interleukin (IL)-1β 
and Fusobacterium nucleatum in the presence and absence of GHRL for 
up to 2 d. Subsequently, gene expressions of GHS-R1a, inflammatory 
mediators and matrix metalloproteinase were analyzed by real-time 
PCR. GHS-R protein synthesis and NF-κB p65 nuclear translocation 
were assessed by immunocytochemistry and immunofluorescence 
microscopy, respectively. IL-1β and F. nucleatum caused a significant 
upregulation of GHS-R1a expression and an increase in GHS-R1a 
protein. Pre-incubation with a MEK1/2 inhibitor diminished the 
IL-1β-induced GHS-R1a upregulation. IL-1β and F. nucleatum also 
enhanced the expressions of cyclooxygenase 2, CC-chemokine ligand 
2, IL-6, IL-8, and matrix metalloproteinase 1, but these stimulatory 
effects were counteracted by GHRL. By contrast, the stimulatory 
actions of IL-1β and F. nucleatum on the GHS-R1a expression were 
further enhanced by GHRL. Our study provides original evidence 
that IL-1β and F. nucleatum regulate the GHS-R/GHRL system in 
osteoblast-like cells. Furthermore, we demonstrate for the first time that 
the proinflammatory and proteolytic actions of IL-1β and F. nucleatum 
on osteoblast-like cells are inhibited by GHRL. Our study suggests that 
microbial and inflammatory insults upregulate GHS-R1a, which may 
represent a protective negative feedback mechanism in human bone.
Keywords: Receptors, Ghrelin; Ghrelin; Osteoblasts; Periodontitis; 
Fusobacterium nucleatum.
Introduction
One of the most common diseases in humans worldwide is 
periodontitis. This chronic inflammatory disease is characterized by 
the destruction of the tooth-supporting tissues and can result in tooth 
loss and reduced quality of life.1,2 Periodontitis is caused by pathogenic 
microorganisms of the subgingival biofilm, such as Fusobacterium 
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nucleatum, together with other risk factors, such 
as smoking, genetic predisposition and several 
systemic diseases.1,2,3,4 The periodontopathogenic 
microorganisms induce an immunoinflammatory 
host response, whose aim is to battle the pathogens 
and, thereby, to stop the microbial attack. A 
plethora of proinflammatory mediators, such as 
interleukin (IL)-1β, IL-6, IL-8, cyclooxygenase 
(COX) 2, and chemokine CC motif ligand (CCL) 2 
(CCL2), as well as proteolytic enzymes like matrix 
metalloproteinase (MMP) 1, are involved in these 
immunoinflammatory processes. Although the host 
response aims to protect the periodontal structures 
against the periodontopathogens, it may cause 
irreversible loss of the periodontal soft and hard 
tissues, if the immunoinflammatory processes are 
extended and/or excessive.3 
Soft and hard tissues homeostasis, destruction, 
and healing are not only regulated by inflammation 
but also by hormones such as ghrelin (GHRL).5,6 GHRL 
is a 28-amino acid peptide which induces the secretion 
of growth hormone at the hypothalamus-pituitary 
axis. GHRL exerts orexigenic and adipogenic effects 
and has been shown to regulate bone metabolism 
in an autocrine and paracrine manner.7 There 
is fundamental evidence that GHRL stimulates 
proliferation and differentiation of osteoblasts 
and inhibits their apoptosis, suggesting that this 
hormone might also be a potential candidate to 
promote periodontal bone healing. Interestingly, 
periodontitis is associated with a great number of 
systemic diseases and conditions such as obesity, 
diabetes mellitus, cardiovascular diseases, and 
metabolic syndrome.8,9 Therefore, GHRL might be a 
pivotal link in the relationships between periodontitis 
and systemic diseases. 
The actions of GHRL are mediated by binding to 
the growth hormone secretagogue receptor (GHS-R) 
which is a G-protein-coupled receptor.10 Two splice 
variants of GHS-R have been found: type 1a and 1b. 
Following binding of GHRL to GHS-R1a, a profound 
change in receptor conformation takes place, which 
then results in a diversity of physiological responses. 
In contrast to the biologically active GHS-R1a, GHS-R1b 
does not mediate any effects.10
It is only recently that the role of GHRL in 
periodontal health and diseases has become the focus 
of attention. Interestingly, GHRL levels in gingival 
crevicular fluid have been shown to be decreased in 
periodontally-diseased patients.11 Moreover, GHRL 
has been found in saliva as well as cells and tissues of 
the tooth germ, such as the inner enamel epithelium, 
mesenchymal cells, ameloblasts, odontoblasts, and 
Hertwig’s epithelial root sheath.12,13,14,15 
Recently, we could demonstrate that inflammatory 
mediators and periodontopathogens are able to induce 
an initial GHS-R1a upregulation in periodontal 
fibroblasts.16,17 Moreover, we found an increased 
GHS-R1a expression at periodontally-diseased sites 
as compared to healthy sites during the early stage 
of periodontitis in a rat experimental periodontitis 
model.17 Our investigations also proved the 
anti-inflammatory nature of GHRL. Our in-vitro 
and in-vivo studies suggested that the GHS-R1a 
upregulation in periodontal fibroblasts in response to 
an inflammatory or microbial stimulus may represent 
a negative feedback mechanism to attenuate the 
initial inflammatory process in periodontal diseases. 
Furthermore, the anti-inflammatory GHRL/GHS-R 
system may, therefore, serve as a promising target 
for the prevention and therapy of periodontitis.16,17 
Since periodontitis has a detrimental impact, not 
only on the soft connective tissue but also on bone, 
a better understanding of the GHRL/GHS-R system 
in hard connective tissue is of utmost importance. 
Therefore, the aim of this in-vitro study was to 
investigate the effect of microbial and inflammatory 
insults on the GHS-R1a expression in human 
osteoblast-like cells.
Methodology
Cell culture and treatment 
Human osteoblast-like MG-63 cells (ATCC, 
CRL-1427TM) were grown in Dulbecco’s minimal 
essential medium (DMEM, Invitrogen, Karlsruhe, 
Germany) supplemented with 10% fetal bovine 
serum (FBS, Invitrogen), 100 U/mL penicillin and 
100 μg/ml streptomycin (Invitrogen) in a humidified 
atmosphere of 5% CO2 at 37°C. Then, 50,000 cells/well 
were seeded on tissue culture plates (Corning, NY, 
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USA) and grown to 80% confluence. Twenty-four 
hours prior to each experiment, the FBS concentration 
was reduced to 1%. The medium was changed every 
other day.
In order to simulate an inflammatory condition 
in vitro, cells were treated with IL-1β (1 ng/ml; 
(PromoKine, Heidelberg, Germany), because 
this proinflammatory cytokine had been widely 
shown to be increased at sites of periodontal 
inflammation.18,19 To mimic a microbial infection in 
vitro, cells were exposed to various concentrations 
of the periodontopathogen F. nucleatum ATCC 25586 
(optical density (OD): 0.05, 0.10, 0.20). F. nucleatum is a 
gram-negative anaerobic microorganism associated 
with both gingivitis and periodontitis.20,21 The bacteria 
were pre-cultivated on Schaedler agar plates (Oxoid, 
Basingstoke, UK) in an anaerobic atmosphere, then 
suspended in phosphate-buffered saline (PBS) 
(OD660 =1.0, equivalent to 1.2×109 bacterial cells/ml) 
and subjected twice to ultra-sonication (160 W for 
15 min). Moreover, in a subset of experiments, cells 
were also incubated with GHRL (20 nM; human 
n-octanoylated ghrelin, Pepta Nova, Sandhausen, 
Germany) in the presence and absence of F. nucleatum 
or IL-1ß. 
In order to unravel intracellular signaling 
pathways involved in the GHS-R regulation, cells 
were pre-treated with a specific MEK1/2 inhibitor 
(U0126; 10 µM; Calbiochem, San Diego, CA, USA) or a 
specific NF-κB inhibitor (PDTC; 10 µM; Calbiochem) 
60 min prior to the stimulation with IL-1ß.
Real-time PCR
Total RNA was extracted using a specific 
RNA extraction kit (Qiagen, Hilden, Germany) 
according to the manufacturer’s protocol. The RNA 
concentration was measured by the NanoDrop 
ND-2000 spectrophotometer (Thermo Fisher Scientific, 
Wilmington, DE, USA), and 500 ng of total RNA 
was reversely transcribed using the iScript™ Select 
cDNA Synthesis Kit (Bio-Rad Laboratories, Munich, 
Germany) according to the manufacturer’s instruction. 
The gene expressions of GHS-R1a, COX2, CCL2, 
IL-6, IL-8, MMP1, and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) as an endogenous control 
were subsequently analyzed by using the iCycler iQ™ 
Real-Time PCR Detection System (Bio-Rad), SYBR 
Green QPCR Master Mix (Bio-Rad) and QuantiTect 
Primers (Qiagen), as in our previous studies.16,17 For 
data analysis, the comparative threshold cycle (CT) 
method was used.
Immunocytochemistry
MG63 cells were seeded on plastic coverslips 
(Thermo Fisher Scientific) of 13 mm diameter placed 
in 24-well plates in the presence and absence of 
F. nucleatum or IL-1ß for 24 h. Afterwards, cells were 
washed twice with PBS (Invitrogen) and fixed in 
4 % paraformaldehyde (Sigma-Aldrich, Munich, 
Germany) at pH 7.4 and at room temperature (RT) 
for 10 min. Next, cells were permeabilized in 0.1 % 
Triton X-100 (Sigma-Aldrich) for 5 min, washed 
again and then blocked using serum block (Dako, 
Hamburg, Germany) for 20 min. After an overnight 
incubation with a rabbit polyclonal primary antibody 
to GHS-R (Abcam, Cambridge, UK, 1:500) in a humid 
chamber at 4°C, cells were washed with PBS and, 
subsequently, incubated with a goat anti-rabbit IgG 
HRP-conjugated secondary antibody (Dako) for 
45 min. After washing, the cells were incubated 
with 3,3’-diaminobenzidine substrate (DAB) for 
5-10 min at RT and then counterstained 5 s in 
Mayer’s hematoxylin solution. Finally, cells were 
mounted with DePeX (SERVA Electrophoresis, 
Heidelberg, Germany) and the production of GHS-R 
was assessed with an Axioskop 2 microscope 
(20×, Carl Zeiss, Germany). The images were captured 
with an AxioCam MRc camera and analyzed with 
the AxioVision 4.7 software (Carl Zeiss). Untreated 
cells were used as a control. 
Immunofluorescence microscopy
MG63 cells were grown on plastic coverslips 
(Thermo Fisher Scientific) of 13 mm diameter placed 
in 24-well plates in the presence and absence of F. 
nucleatum or IL-1ß for up to 60 min. Afterwards, the 
cells were washed with PBS, fixed and permeabilized 
as described above and blocked with nonfat dry 
milk (Bio-Rad) for 1 h. After washing, the cells were 
incubated with a rabbit anti-nuclear factor (NF)-κB p65 
primary antibody (E498; Cell Signaling Technology, 
Danvers, MA, USA, 1:100) at RT for 90 min. After the 
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incubation step, cells were washed twice with PBS and 
incubated with a CY3-conjugated goat anti-rabbit IgG 
secondary antibody (Abcam; 1:1000) at RT for 45 min. 
The NF-κB p65 nuclear translocation was observed 
by using the ZOE™ Fluorescent Cell Imager (Bio-Rad) 
with a 20× objective and an integrated digital 5MP 
CMOS camera. Untreated cells were used as a control. 
Statistical analysis
Data analysis was performed using the IBM SPSS 
Statistics 22 software (IBM SPSS, Chicago, USA). For 
quantitative analysis, mean values and standard 
errors of the mean (SEM) were calculated. In order 
to test for significant (p < 0.05) differences between 
groups, parametric (t-test and ANOVA followed 
by the post-hoc Dunnett’s and Tukey’s tests) and 
non-parametric tests (Wilcoxon and Mann-Whitney-U 
tests) were applied. All experiments were performed 
in triplicate and repeated at least twice.  
Results
Regulation of GHS-R1a in MG63 cells by F. 
nucleatum or IL-1β
As depicted in Figure 1A, F. nucleatum caused a 
significant upregulation of GHS-R1a by more than 
50 % at 1 d and 2 d, as analyzed by real-time PCR. 
Interestingly, the stimulatory effect of F. nucleatum 
on GHS-R1a was significantly increased at the OD 
concentration of 0.1 (Figure 1B). When osteoblasts were 
exposed to IL-1β, the constitutive GHS-R1a expression 
was more than doubled at 1 d and 2 d (Figure 1C). 
Further analysis by immunocytochemistry revealed 
that the GHS-R1a upregulation by F. nucleatum 
or IL-1β at transcriptional level was paralleled at 
protein level. The immunoreactivity against GHS-R1a 
was strongly enhanced in osteoblasts treated with 
F. nucleatum or IL-1β, as compared with untreated 
cells (Figure 1D).
Intracellular signaling involved in the 
GHS-R1a regulation by F. nucleatum or 
IL-1β in MG63 cells
As shown in Figure 2A, exposure of MG63 cells to 
F. nucleatum or IL-1β resulted in a pronounced NF-κB 
(p65) nuclear translocation between 30 min and 60 min, 
as determined by immunofluorescence microscopy. 
However, pre-incubation of cells with a specific 
inhibitor of NF-κB signaling had no significant effect 
on the GHS-R1a expression induced by F. nucleatum 
or IL-1β (data not shown). Nevertheless, when cells 
were pre-incubated with a specific inhibitor against 
MEK1/2, the IL-1β-induced GHS-R1a upregulation 
was significantly diminished, as revealed by real-
time PCR (Figure 2B).   
Antiinflammatory and antiproteolytic 
effects of GHRL on MG63 cells under 
microbial condition 
Both F. nucleatum and IL-1β increased significantly 
the expressions of COX2, CCL2, IL-6, IL-8, and MMP1 
at 1 d (Figure 3A-E and Figure 4A-E). However, when 
the cells were simultaneously incubated with GHRL, 
the stimulatory actions of F. nucleatum or IL-1β on 
MG63 cells were significantly reduced (Figure 3A-E 
and Figure 4A-E).
GHS-R1a expression in MG63 cells in 
response to GHRL under microbial and 
inflammatory conditions
As demonstrated in Figures 5A and B, the GHS-R1a 
expression was significantly upregulated by GHRL at 
1 d. The GHRL-stimulated GHS-R1 expression was 
even more increased when the cells were exposed 
to a combination of GHRL with F. nucleatum or IL-1β 
(Figures 5A and B). 
Discussion 
Our study provides original evidence that 
the periodontopathogen F. nucleatum and the 
proinflammatory cytokine IL-1β, which have been 
shown to be increased at inflamed periodontal sites, 
regulate the GHS-R1/GHRL system in osteoblast-like 
cells. Furthermore, we demonstrate for the first time 
that the proinflammatory and proteolytic actions 
of F. nucleatum and IL-1β on the osteoblast-like cells 
can be counteracted by GHRL. Our study suggests 
that microbial and inflammatory insults upregulate 
GHS-R1a, which may represent a protective negative 
feedback mechanism in human bone.
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GHRL is a potent growth hormone secretagogue, 
which is mainly produced by endocrine cells of 
the gastric oxyntic mucosa and linked to many 
physiological and pathophysiological aspects, such 
as bone metabolism, in addition to growth.22,23 
GHRL promotes proliferation and differentiation, 
as evidenced by matrix mineralization, alkaline 
phosphatase activity, osteoblast-specific gene 
*significant (p < 0.05) difference between groups.
Figure 1. (A) GHS-R1a expression in the presence and absence of F. nucleatum (Fn; OD: 0.1) at 1 d and 2 d. Mean ± SEM (n=9). 
(B) GHS-R1a expression in response to various concentrations of F. nucleatum (Fn; OD: 0.05, 0.10, 0.20) at 1 d. Untreated cells 
served as control. Mean ± SEM (n=9). (C) GHS-R1a expression in the presence and absence of IL-1β (1 ng/ml) at 1 d and 2 d. 
Mean ± SEM (n=9). (D) GHS-R1a immunoreactivity in the presence and absence of F. nucleatum (OD: 0.1) or IL-1β (1 ng/ml) at 
1 d. Representative images from one out of three experiments are shown.
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expression, calcium accumulation in the matrix, 
inhibition of osteoblastic cells apoptosis, and 
exerts anabolic effect on osseous tissue.7,24-26 GHRL 
has a positive relationship with the trabecular 
bone density.27 However, the actions of GHRL on 
osteoclastogenesis are contradictory and it has 
even been postulated that the physiological effect 
of ghrelin on osteoclasts may be limited.28 In-vivo 
*significant (p < 0.05) difference between groups.
Figure 2. (A) NF-κB (p65) nuclear translocation in response to F. nucleatum (Fn; OD: 0.1) or IL-1β (1 ng/ml) over time. Representative 
images from one out of three experiments are shown. Indicator arrows show some cells presenting nuclear translocation of p65 
at 60 min. (B) GHS-R1a expression in response to IL1β (1 ng/ml) in the presence and absence of a MEK1/2 inhibitor (U0126; 10 
µM) at 1 d. Mean ± SEM (n=3).
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studies have demonstrated that intraperitoneal 
and central administration of GHRL enhance 
bone mineral density and mass.27 Notably, GHS-
R-null mice have a low bone mass phenotype with 
poor bone formation. Restoring the expression 
of GHS-R specifically in osteoblasts, and not 
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Figure 3. Expression of COX2 (A), CCL2 (B), IL-6 (C), IL-8 (D) and MMP1 (E) in response to F. nucleatum (Fn; OD: 0.1) in the 
presence and absence of GHRL (20 nM) at 1 d. Unstimulated cells served as control. Mean ± SEM (n = 3).
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in osteoclasts or the central nervous system, 
ameliorated bone abnormalit ies in GHS-R-
null mice, which indicates that the osteoblastic 
expression of GHS-R is necessary and sufficient 
for the bone anabolic actions of GHRL.28 GHRL 
promotes osteogenesis of intramembranous bone 
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Figure 4. Expression of COX2 (A), CCL2 (B), IL-6 (C), IL-8 (D) and MMP1(E) in response to IL-1β (1 ng/ml) in the presence and 
absence of GHRL (20 nM) at 1 d. Untreated cells served as control. Mean ± SEM (n=3).
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and improves the repair of calvarial bone defect 
in rats.29 Furthermore, clinical studies showed a 
positive association between circulating GHRL 
levels and trabecular bone mineral density in women 
and elderly men.27 Moreover, gastrectomy results 
rapidly in osteopenia, independent of nutritional 
defects such as insufficient calcium absorption, 
which underlines the critical role of the stomach 
in bone remodeling.30,31 Taken together, there is 
convincing evidence that GHRL exerts stimulatory 
effects on bone metabolism. GHRL has also been 
shown to be present in human osteoblasts and 
bone biopsies, suggesting an autocrine/paracrine 
role.34 Pacheco-Pantoja et al. have demonstrated 
GHRL and GHS-R1a in osteoblast-like MG63 
cells.35  Taken together, the aforementioned studies 
show that GHRL can promote bone formation 
and, thereby, prevent bone loss.7 Interestingly, 
F. nucleatum and IL-1β caused an upregulation of 
the functional receptor for GHRL in the present 
study, which suggests that the host may use this 
mechanism to maintain the bone volume and 
structure despite the presence of pathogens or 
inflammatory mediators. Our previous studies on 
the GHRL/GHS-R1 system in fibroblasts support 
this assumption.16,17 In addition to its beneficial 
actions on osteogenesis, GHRL has also the ability 
to inhibit inflammation.9,24  In the present study, 
GHRL counteracted the proinflammatory and 
proteolytic effects of F. nucleatum and IL-1β on 
the osteoblast-like cells, which concurs with our 
previous findings in periodontal fibroblasts.16,17 
Both F. nucleatum and IL-1β induced an increase 
in the expressions of COX2, CCL2, IL-6, IL-8, and 
MMP1, which stimulate inflammation and thereby 
bone resorption. Therefore, the upregulation of the 
functional receptor for GHRL may not only protect 
bone loss through stimulation of osteogenesis 
but also through inhibition of bone resorption by 
reducing the proinflammatory effects of F. nucleatum 
and IL-1β. Cells response and tissues homeostasis 
can be affected by changes in ghrelin levels due 
to different physiological and/or pathological 
circumstances. Notably, GHRL stimulated the 
expression of its own receptor, suggesting a positive 
feedback to further amplify the bone-protective and 
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Figure 5. (A) GHS-R1a expression in response to GHRL (20 nM) in the presence and absence of F. nucleatum (Fn; OD: 0.1) at 1 
d. Untreated cells served as control. Mean ± SEM (n=6). (B) GHS-R1a expression in response to GHRL (20 nM) in the presence 
and absence of IL-1β (1 ng/ml) at 1 d. Untreated cells served as control. Mean ± SEM (n=6).
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anti-inflammatory actions. However, the protective 
mechanisms may get lost at later stages of soft and 
hard tissue inflammation, as our previous in-vitro 
and in-vivo studies16,17 have demonstrated that the 
continuous exposure to the inflammatory stimuli 
leads to a decrease in the expression of GHRL. 
We also sought to unravel the intracellular 
signaling pathways involved in the stimulatory 
actions of F. nucleatum and IL-1β on GHS-R1a in 
osteoblast-like cells. Although both stimuli triggered 
an NF-κB nuclear translocation, pre-incubation of the 
cells with a specific inhibitor against NF-κB, did not 
abrogate the stimulatory effects of F. nucleatum and 
IL-1β, indicating that NF-κB might not be involved in 
the GHS-R1a upregulation. However, the GHS-R1a 
expressions induced by F. nucleatum or IL-1β was 
partially reduced in the presence of a specific inhibitor 
against MEK1/MEK2, two important components of 
the MAP kinase signaling pathway. Future studies 
should clarify what other signaling pathways are 
involved in the GHS-R1a regulation. 
As in our previous studies, F. nucleatum was 
used to mimic microbial conditions in vitro.17,36,37 
This gram-negative, anaerobic microorganism 
acts as a bridge bacterium between early- and 
late-colonizing bacteria during plaque development, 
can invade periodontal cells, and is associated with 
both gingivitis and periodontitis.20,21 However, since 
periodontitis is a polymicrobial disease, further 
experiments should also focus on the effects of 
other periodontopathogens or their combinations. 
Moreover, a sonicated lysate of F. nucleatum was 
applied in our experiments. Lipopolysaccharide, 
which binds to the toll-like receptor 2 and 4, as our 
previous studies have shown, might have been the 
major compound of this lysate.17,36 Nevertheless, 
other virulence factors of F. nucleatum may also have 
participated in the GHS-R1a upregulation observed 
in our study. In our experiments, IL-1β was used to 
mimic inflammatory conditions in vitro, because 
this proinflammatory cytokine had been shown 
to be increased at inflamed periodontal sites.18,19 
Nevertheless, inflammation comprises a plethora of 
molecules, and further studies should also investigate 
their impact on the GHRL/GHS-R1a system. The 
applied concentrations of F. nucleatum, IL-1β and 
GHRL were in the physiological range and the same 
as in our previous studies.16,17,36,37 
In the present study, osteoblast-like MG63 cells 
were used instead of primary bone cells to avoid 
biological variations and to obtain reproducible 
results.38,39 However, further studies should also 
involve primary alveolar osteoblasts to validate 
our findings. Moreover, the use of coculture models 
and ghrelin-knockout mice will further add to our 
understanding of the GHRL/GHS-R1a system under 
more complex and realistic conditions. Furthermore, 
GHRL might also mediate its effects on bone cells by 
binding to other receptors than GHS-R1a, which is 
another exciting topic of future research. 
The present study expands the knowledge from 
our previous studies on the GHRL/GHS-R1 system 
in periodontal fibroblasts and soft tissue to bone 
cells. Since the periodontium also comprises hard 
tissues, such as bone, the findings of the present 
study are of utmost importance and contribute to a 
better understanding of the GHRL/GHS-R1 system 
in the entire periodontium. The GHRL/GHS-R1a 
system may serve as a potential target in periodontal 
disease and healing.
Conclusion
Our study provides original evidence that 
the periodontopathogen F. nucleatum and the 
proinflammatory cytokine IL-1β, which have been 
shown to be increased at inflamed periodontal sites, 
regulate the GHS-R1/GHRL system in osteoblast-like 
cells. Furthermore, we demonstrate for the first time 
that the proinflammatory and proteolytic actions 
of F. nucleatum and IL-1β on the osteoblast-like cells 
can be counteracted by GHRL. Our study suggests 
that microbial and inflammatory insults upregulate 
GHS-R1a, which may represent a protective negative 
feedback mechanism in human bone.
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